Brief: BrightPath Biotherapeutics says collaboration with The University of Tokyo

BrightPath Biotherapeutics Co

24/07/2017 08:11

July 24 (Reuters) - BrightPath Biotherapeutics Co Ltd 
 4594.T  
    
    * Says the University of Tokyo plans to grant the exclusive 
license of a patent(number: P6164746) regarding antigen-specific 
T cell to co's Tokyo-based unit 
 
    Source text in Japanese: https://goo.gl/HV5hB3 
    Further company coverage: 4594.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724; 
Reuters Messaging: Tingting.liu@thomsonreuters.com@reuters.net))